Theriva Biologics
TOVX
TOVX
27 hedge funds and large institutions have $5.8M invested in Theriva Biologics in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.58M | |
| 2 | +$1.35M | |
| 3 | +$655K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$574K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$393K |
Top Sellers
| 1 | -$474K | |
| 2 | -$28K | |
| 3 | -$6K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6K |